You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
This book sheds new light on “inducible” lymphoid organs (ILOs): antigen presentation sites that are generated de novo in peripheral tissues under various pathogenic conditions. Accomplished immunologists demonstrate that the physiological role of these ILOs is completely different from that of central lymphoid organs, i.e., the lymph nodes or spleen. In addition to the central organs, the ILOs are considered essential structures for the efficient elicitation of adaptive immune responses in lesions. The respective chapters highlight examples from multiple sites, e.g. the skin, lung, intestinal tract, genital tract, the synovial membrane of the joints and artificial lymph nodes. Accordingly, readers will learn that ILO structure and function can vary substantially, depending on the context. Presenting the results of the latest immunological research, the book offers a fascinating and insightful read for both scientists and clinicians in the areas of infectious and immune-associated diseases.
Dr. Baer is the site PI for a clinical trial investigating treatments related to Sjogren’s Syndrome, in conjunction with Viela Bio. The other Topic Editors declare no competing interests with relation to the topic theme.
Rheumatology in Practice offers chapters which are organised and built around anatomical and regional syndromes, so reinforcing the evidence-based approach. As readers progress through the text they are given more demanding and challenging questions, encouraging them to use their diagnostic skills to identify the main syndromes and the underlying diseases responsible for the disorders in question. The text is lavishly illustrated in full colour, with detailed photos of patient examinations, complemented by radiographs and full colour line illustrations. The text also benefits from the use of summaries using coloured boxing to identify key points in diagnosis and management. Written by two of the most respected clinicians in the discipline, this book will be essential reading for rheumatologists in practice and training.
This issue covers the latest developments in the understanding of rheumatoid arthritis at the early stage. Treatments such as with newer biologic agents and conventional disease-modifying antirheumatic drugs are reviewed. Also included are articles on imaging modalities as a means of identifying those in the early stages and monitoring response to treatment.